China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares (SXTC)
SXTC moved a median of -0.85% 30 minutes after news, and -2.34% by the close. How SXTC actually reacts to news — the realized, point-in-time move the market made, measured across 70 labeled events over the last three years with zero look-ahead.
SXTC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.23% | 37% | 54 |
| 30-min | -0.85% | 34% | 56 |
| 60-min | -1.41% | 34% | 64 |
| to close | -2.34% | 29% | 68 |
| Middle 50% of SXTC reactions | -4.45% to +1.71% |
|---|---|
| Median reaction (30-min) | -0.85% |
| Measured reactions | 70 |
Half of all China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares news events land between -4.45% and +1.71% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when SXTC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SXTC's baseline. Nothing else.
Recent SXTC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K China SXT Pharmaceutical For: Oct 09 | SEC filing · Form 6-K | SEC EDGAR | -2.90% | +2.00% | |
| Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) | Press release | GlobeNewswire | -2.90% | +2.00% | |
| China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering | Press release | PR Newswire | -18.14% | -26.00% | |
| Form 6-K China SXT Pharmaceutical For: Oct 08 | SEC filing · Form 6-K | SEC EDGAR | -18.14% | -26.00% | |
| Form EFFECT China SXT Pharmaceutical | SEC filing · Form EFFECT | SEC EDGAR | -1.29% | +4.51% | |
| Form 6-K China SXT Pharmaceutical For: Aug 28 | SEC filing · Form 6-K | SEC EDGAR | +0.49% | -15.51% | |
| Form F-3/A China SXT Pharmaceutical | SEC filing · Form F-3 | SEC EDGAR | +0.49% | -15.51% | |
| China SXT Pharmaceuticals, Inc. Announces Share Consolidation | Press release | GlobeNewswire | +6.57% | -6.29% | |
| Form 6-K China SXT Pharmaceutical For: Jul 24 | SEC filing · Form 6-K | SEC EDGAR | +4.68% | +7.05% | |
| Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) | Press release | GlobeNewswire | +4.68% | +7.05% | |
| China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering | Press release | GlobeNewswire | +12.28% | -18.26% | |
| Form F-3 China SXT Pharmaceutical | SEC filing · Form F-3 | SEC EDGAR | — | +5.37% | |
| Form 6-K China SXT Pharmaceutical For: Jul 06 | SEC filing · Form 6-K | SEC EDGAR | +0.01% | +6.49% | |
| Form 20-F China SXT Pharmaceutical For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | +0.00% | -2.00% | |
| Form 6-K China SXT Pharmaceutical For: Jun 01 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +6.59% | |
| Form 6-K China SXT Pharmaceutical For: May 04 | SEC filing · Form 6-K | SEC EDGAR | +5.23% | -5.79% | |
| Form 6-K China SXT Pharmaceutical For: Apr 09 | SEC filing · Form 6-K | SEC EDGAR | -5.00% | -5.91% | |
| China SXT Pharmaceuticals, Inc. Announces Share Re-classification | Press release | GlobeNewswire | — | — | |
| China SXT Pharmaceuticals, Inc. Announces Share Consolidation | Press release | GlobeNewswire | -4.54% | -25.84% | |
| CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN | Press release | GlobeNewswire | +2.85% | +8.15% | |
| Form 6-K China SXT Pharmaceutical For: Jan 13 | SEC filing · Form 6-K | SEC EDGAR | -4.04% | -15.53% | |
| Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) | Press release | GlobeNewswire | -4.04% | -15.53% | |
| China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering | Press release | GlobeNewswire | -19.66% | -73.04% | |
| CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT | Press release | GlobeNewswire | +23.15% | -38.42% | |
| Form 6-K China SXT Pharmaceutical For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | — | +8.12% | |
| Form EFFECT China SXT Pharmaceutical | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +1.50% | |
| Form F-3 China SXT Pharmaceutical | SEC filing · Form F-3 | SEC EDGAR | +2.86% | -0.71% | |
| Form POS AM China SXT Pharmaceutical | SEC filing · Form POS | SEC EDGAR | +2.86% | -0.71% | |
| Form 20-F China SXT Pharmaceutical For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | -1.25% | -1.89% | |
| Form 6-K China SXT Pharmaceutical For: Jul 29 | SEC filing · Form 6-K | SEC EDGAR | -4.46% | — | |
| Form 6-K China SXT Pharmaceutical For: Jul 15 | SEC filing · Form 6-K | SEC EDGAR | — | -0.71% | |
| Form 6-K China SXT Pharmaceutical For: Jun 16 | SEC filing · Form 6-K | SEC EDGAR | -1.11% | -3.89% | |
| Form 6-K China SXT Pharmaceutical For: May 13 | SEC filing · Form 6-K | SEC EDGAR | -0.45% | -1.90% | |
| Form 6-K China SXT Pharmaceutical For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | +2.22% | +1.80% | |
| Form S-8 China SXT Pharmaceutical | SEC filing · Form S-8 | SEC EDGAR | -1.28% | -1.86% | |
| Form 6-K China SXT Pharmaceutical For: Mar 19 | SEC filing · Form 6-K | SEC EDGAR | -1.41% | -4.25% | |
| China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency | Press release | GlobeNewswire | -2.58% | -9.34% | |
| China SXT Pharmaceuticals, Inc. Announces Share Consolidation | Press release | GlobeNewswire | +5.08% | -16.01% | |
| Form 6-K China SXT Pharmaceutical For: Jan 27 | SEC filing · Form 6-K | SEC EDGAR | -7.81% | -5.70% | |
| Form 6-K China SXT Pharmaceutical For: Jan 23 | SEC filing · Form 6-K | SEC EDGAR | +3.75% | +8.00% | |
| Form EFFECT China SXT Pharmaceutical | SEC filing · Form EFFECT | SEC EDGAR | -0.72% | +4.45% | |
| Form F-3 China SXT Pharmaceutical | SEC filing · Form F-3 | SEC EDGAR | -0.02% | -3.02% | |
| Form 6-K China SXT Pharmaceutical For: Oct 15 | SEC filing · Form 6-K | SEC EDGAR | -1.52% | -7.54% | |
| China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency | Press release | GlobeNewswire | -1.29% | -7.16% | |
| Form 20-F China SXT Pharmaceutical For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | — | -2.83% | |
| Form NT 20-F China SXT Pharmaceutical For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -1.82% | |
| Form 6-K China SXT Pharmaceutical For: May 14 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -3.54% | |
| Form 6-K China SXT Pharmaceutical For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | -2.33% | -1.74% | |
| Form S-8 China SXT Pharmaceutical | SEC filing · Form S-8 | SEC EDGAR | -3.82% | -10.05% | |
| China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule | Press release | GlobeNewswire | +1.22% | +2.85% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SXTC section they belong to.
Where else SXTC is measured.
SXTC earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares's median reaction calculated?
Every labeled SXTC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 70 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 34% of SXTC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SXTC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.